Why equine prepurchase exams are getting more complex

Equine Management is spotlighting how equine prepurchase exams have shifted from a relatively straightforward screening into a higher-stakes risk assessment shaped by rising horse values, more extensive imaging, insurance considerations, and greater litigation pressure. In its May 22 report, Alexandra Beckstett summarized discussion from the March 5, 2026 National Equine Forum, where veterinarians and industry participants said today’s PPE is less about “pass or fail” and more about whether a specific horse is suitable for a specific buyer’s intended use. The panel also emphasized that findings can change with management, workload, rider, and environment, making clear communication and careful documentation central to the process. (equimanagement.com)

Why it matters: For equine veterinarians, the story is a reminder that PPEs are as much about expectation-setting as diagnostics. Merck notes that PPEs in the U.S. aren’t standardized and can range from a basic physical and soundness exam to a far more comprehensive workup with imaging, laboratory testing, and video documentation. Cornell and AAEP materials similarly stress that the veterinarian’s role is to assess risk at a single point in time, not guarantee future performance, which raises the stakes for informed consent, conflict-of-interest disclosure, private communication with the buyer or their representative, and a written record that explains both findings and limitations. (merckvetmanual.com)

What to watch: Expect continued debate over standardization, radiograph interpretation, seller disclosure tools, and whether clearer PPE frameworks can reduce disputes while keeping equine practitioners willing to offer the service. (beva.org.uk)